The deceleration in CKD prevalence growth after 2012, along with the declining incidence trends may reflect the impact of the ...
Pfizer's Conor Riordan explains how the pharmaceutical giant uses Celonis across 200+ markets to drive toward 95% order ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback